Health care stocks were flat to higher premarket Thursday, with The Health Care Select Sector SPDR Fund (XLV) up 0.2% and the iShares Biotechnology ETF (IBB) inactive.
Soleno Therapeutics (SLNO) shares were up 35% after the company said overnight that the US Food and Drug Administration has approved its treatment for hyperphagia in adults and children with Prader-Willi Syndrome, a rare genetic disorder.
Bausch + Lomb (BLCO) stock was more than 4% lower after the company said it is voluntarily recalling the intraocular lenses on its enVista platform after reports of complications.
Ascentage Pharma Group (AAPG) shares were up over 10% after the company reported a narrower 2024 loss as revenue rose during the period.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。
沒有相關數據
如果下載按鈕點擊無跳轉,請點擊右上角菜單選擇 “在瀏覽器打開”